Skip to main content
SpringerLink
Log in

Strategies to Delay the Onset of Clinically Definite Multiple Sclerosis in Patients with Monosymptomatic Presentations of Optic Neuritis, Brainstem Syndromes or Myelopathy

  • Chapter
Multiple Sclerosis

  • 121 Accesses

Abstract

Converging lines of evidence suggest that it is now possible definitively to test strategies to delay the onset of clinically definite multiple sclerosis (CDMS) in patients who experience first attacks of optic neuritis, brainstem syndromes or myelitis. It has been demonstrated that brain magnetic resonance imaging (MRI) can identify patients with monosymptomatic presentations who subsequently are at high risk to develop CDMS. There is also evidence to suggest that the development of CDMS following isolated optic neuritis can be delayed by administering intravenous corticosteroids. A study to investigate this question further in monosymptomatic patients is now particularly relevant for several reasons. It has been shown that treatment can have a beneficial effect on the course of early relapsing-remitting MS and in vitro data from studies of experimental allergic encephalomyelitis (an animal model of multiple sclerosis) provide a potential explanation for why treatment at the time of an initial monosymptomatic event (e.g. optic neuritis) might have greater efficacy than treatment once CDMS is well established. In this chapter we will review evidence supporting the need for such a study as well as aspects of study design that must be properly addressed to assure its successful completion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Acha Orbea H, Mitchell DJ, Timmermann L et al. (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoinunune encephalomyelitis allows specific immune intervention. Cell 54: 263

    Article  Google Scholar 

  • Allegrett M, Nicklas JA, Sriram S et al. (1990) T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718

    Article  PubMed  Google Scholar 

  • Alvord EC, Kies MW, Suckling AJ (ed) (1984) Experimental allergic encephalomyelitis: a useful model for multiple sclerosis. New York: Liss (Progress in clinical and biological reseach)

    Google Scholar 

  • Beck RW, Trobe JD (1995) The Optic Neuritis Treatment Trial: putting the results in perspective. J Clin Neuro-ophthalmol 15: 131–135

    CAS  Google Scholar 

  • Beck RW, Cleary PA, Anderson MMJ et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326: 581–588

    Article  PubMed  CAS  Google Scholar 

  • Beck RW, Arrington J, Murtagh FR, Cleary PA, Kaufman DI (1993a) Optic neuritis study: brain MRI in acute optic neuritis. Experience of the Optic Neuritis Study Group. Arch Neurol 8: 841–846

    Google Scholar 

  • Beck RW, Cleary PA, Optic Neuritis Study Group (1993b) Optic neuritis treatment trial: one-year follow-up results. Arch Ophthalmol 111: 773–775

    CAS  Google Scholar 

  • Beck RW, Cleary PA, Trobe JD et al. (1993c) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. New Engl J Med 329: 1764–1769

    Article  PubMed  CAS  Google Scholar 

  • Bornstein MB, Johnson KP (1992) Treatment of multiple sclerosis with copolymer 1. In: Rudick RA,Goodkin DE (eds) Treatment of multiple sclerosis. Springer-Verlag, New York, pp 173–198

    Google Scholar 

  • Bornstein MB, Miller A, Slagle S et al. (1987) A pilot trial of COP 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317: 408–414

    Article  PubMed  CAS  Google Scholar 

  • Bornstein MB, Miller A, Slagle S et al. (1991) A placebo controlled, double-blind, randomized, two- center pilot trial of COP I in chronic progressive multiple sclerosis. Neurology 41: 533–539

    PubMed  CAS  Google Scholar 

  • Camenga DL, Johnson KP, Alter M (1986) Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch Neurol 43: 1239–1246

    PubMed  CAS  Google Scholar 

  • Chrousos GA, Kattah JC, Beck RW, Cleary PA, Optic Neuritis Study Group (1993) Side effects of glucocorticoid treatment: experience of the Optic Neuritis Treatment Trial. JAMA 269: 2110 2112

    Article  PubMed  CAS  Google Scholar 

  • Corbett JJ, Cruse JM (1993) Corticosteroids and optic neuritis. Neurology 43: 634

    Google Scholar 

  • Cross AH, Tuohy VK, Raine CS (1993) Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 146: 261

    Article  PubMed  Google Scholar 

  • Durelli L, Bongioanni MR, Cavalo R et al. (1994) Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MM signs of disease activity and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology 44: 406–413

    PubMed  CAS  Google Scholar 

  • Ellison GW, Meyers LW, McKey MR et al. (1989) A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methyiprednisolone in multiple sclerosis. Neurology 39: 1087–1126

    Google Scholar 

  • Filippi M, Horsfield MA, Morrissey SP et al. (1994) Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44: 635–641

    PubMed  CAS  Google Scholar 

  • Ford B, Tampieri D, Francis G (1992) Long-term follow-up of acute partial transverse myelopathy. Neurology 42: 250–252

    PubMed  CAS  Google Scholar 

  • Frederiksen JL, Larsson HBW, Henriksen O, Olesen J (1989) Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand 80: 512–517

    Article  PubMed  CAS  Google Scholar 

  • Giang D, Goodman A, Mattson D, Schiffer R, Cohen N, Ader R (1996) Can immunomodulatory effects of cyclophosphamide be conditioned in humans? J Neuropsychiatr Clin Neurosci (in press)

    Google Scholar 

  • Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF (1991) Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 29: 548–555

    Article  PubMed  CAS  Google Scholar 

  • Haynes BF, Fauci AS (1978) The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest 61: 703–707

    Article  PubMed  CAS  Google Scholar 

  • Heath WR, Allison j, Hoffmann MW et al. (1992) Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359: 547

    Article  PubMed  CAS  Google Scholar 

  • Hood L, Kumar V, Osaman G et al. (1989) Autoimmune disease and T-cell immunologic recognition. Cold Spring Harb Symp Quant Biol 54: 859

    PubMed  CAS  Google Scholar 

  • IFN-B Multiple Sclerosis Study Group (1993) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 48: 655–661

    Google Scholar 

  • Isaac C, Li DK, Genton M et al. (1988) Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 38: 1511–1515

    PubMed  CAS  Google Scholar 

  • Jacobs L, Munschauer FE, Kaba SE (1991) Clinical and magnetic resonance imaging in optic neuritis. Neurology 41: 15–19

    PubMed  CAS  Google Scholar 

  • Jacobs L, Cookfair D, Rudick R, Herndon R et al. (1993) A phase III trial of recombinant beta interferon as treatment for multiple sclerosis. Ann Neurol 34: 310

    Google Scholar 

  • Jacobs L, Brownscheidle C, Cookfair D, Rudick RA, The Multiple Sclerosis Collaborative Research Group (1994) Recombinant interferon-beta as treatment for multiple sclerosis. Arthritis Foundation, Atlanta, GA, pp 103–112 (Proceedings: Early decisions in DMARD development: III. Biologic agents in autoimmune disease vol. 3 )

    Google Scholar 

  • Kastrukoff LF, Oger JJ, Hashimoto SA et al. (1990) Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerois. I. Clinical and MRI evaluation. Neurology 40: 479–486

    PubMed  CAS  Google Scholar 

  • Kaufmann DL, Clare-Salzler M, Tian J et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in insulin-dependent diabetes. Nature 366: 69

    Article  Google Scholar 

  • Kinkel RP, Goodkin DE (1994) Immunotherapy for multiple sclerosis: a review of the clinical experience. Clin Immunother 1: 117–134

    Google Scholar 

  • Kitze B, Pette M, Rohrbach E et al. (1988) Myelin-specific T lymphocytes in multiple sclerosis patients and healthy individuals. J Neuroimmunol 20: 237

    Article  PubMed  CAS  Google Scholar 

  • Kotzin BL, Karuturi S, Chou YK et al. (1991) Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 88: 9161

    Article  PubMed  CAS  Google Scholar 

  • Kupersmith MJ, Kaufman D, Paty DW et al. (1994) Megadose corticosteroids in multiple sclerosis. Neurology 44: 1–4

    PubMed  CAS  Google Scholar 

  • Lee KH, Hashimoto SA, Hooge JP et al. (1991a) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis. Neurology 41: 657–660

    PubMed  CAS  Google Scholar 

  • Lee SJ, Wucherpfennig KW, Brod SA et al. (1991b) Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 29: 23

    Article  CAS  Google Scholar 

  • Lehmann PV, Forsthuber T, Miller A et al. (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155

    Article  PubMed  CAS  Google Scholar 

  • Martin R, Howell MD, Jaraquemada D et al. (1991) A myelin basic protein peptide is recognized by cytotoxic T-cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173: 19

    Article  PubMed  CAS  Google Scholar 

  • Martin R, Utz U, Coligan JE et al. (1992) Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87–106. J Immunol 148: 1359

    PubMed  CAS  Google Scholar 

  • Martinelli V, Comi G, Filippi M, et al. (1991) Paraclinical tests in acute-onset optic neuritis, basal data and results of a short follow up. Acta Neurol Scand 84: 231–236

    Article  PubMed  CAS  Google Scholar 

  • McFarland HF, Frank JA, Alber PS et al. (1992) Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32: 758–766

    Article  PubMed  CAS  Google Scholar 

  • Miller DH, Ormerod IEC, McDonald WI et al. (1988) The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 51: 1569–1571

    Article  PubMed  CAS  Google Scholar 

  • Miller DH, Barkhof F, Kappos L, Scotti G, Thompson AJ (1991) Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54: 683–688

    Article  PubMed  CAS  Google Scholar 

  • Mix E, Olsson T, Correale J et al. (1990) CD4+, CD8+, and CD4-, CD8- T-cells in CSF and blood of patients with multiple sclerosis and tension headache. Scand J Immunol 31: 493–501

    Article  PubMed  CAS  Google Scholar 

  • Morrissey SP, Miller DH, Kendall BE et al. (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116: 135–146

    Article  PubMed  Google Scholar 

  • Noseworthy JH, Hopkins MB, Vandervoort MK et al. (1993) An open-trial evaluation of mitoxantrone in the treatment of progressive MS. Neurology 43: 1401–1406

    PubMed  CAS  Google Scholar 

  • Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R (1994) The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 44: 16–20

    PubMed  CAS  Google Scholar 

  • Ota K, Matsui M, Milford EL et al. (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183

    Article  PubMed  CAS  Google Scholar 

  • Panitch HS, Hirsh RL, Haley AS et al. (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1: 893–895

    Article  PubMed  CAS  Google Scholar 

  • Paty DW, Li DKB, UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group (1993) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 662–667

    Google Scholar 

  • Perkin GD, Rose FC (1979) Optic neuritis and its differential diagnosis. New York: Oxford University Press

    Google Scholar 

  • Pette M, Fujita K, Kitze B et al. (1990a) Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40: 1770

    PubMed  CAS  Google Scholar 

  • Pette M, Fujita K, Wilkinson D et al. (1990b) Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patient and healthy donors. Proc Natl Acad Sci USA 87: 7968

    Article  PubMed  CAS  Google Scholar 

  • Poser CM, Paty DW, Scheinberg L, McDonald WI et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227–231

    Article  PubMed  CAS  Google Scholar 

  • Raine CS (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 50: 608–635

    PubMed  CAS  Google Scholar 

  • Reder AT, Thapar M, Jensen MA (1994) A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain disease. Neurology 44: 2289–2294

    PubMed  CAS  Google Scholar 

  • Richert JR, Robinson ED, Johnson AH et al. (1991) Heterogeneity of the T-cell receptor beta gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann Neurol 29: 299

    Article  PubMed  CAS  Google Scholar 

  • Sarvetnick N, Shizuru J, Liggit D et al. (1990) Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 346: 844

    Article  PubMed  CAS  Google Scholar 

  • Smith ME, Stone LA, Albert PS et al. (1993). Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 33: 480–489

    Article  PubMed  CAS  Google Scholar 

  • Troiano JR, Cook SD, Dowling PC (1987) Steroid therapy in multiple sclerosis [Point of view]. Arch Neurol 44: 803–807

    PubMed  CAS  Google Scholar 

  • Urban JL, Kumar V, Kono DH et al. (1988) Restricted use of T cell receptor V genes in immune autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54: 577

    Article  PubMed  CAS  Google Scholar 

  • Whitaker JN, McFarland HF, Rudge P, Reingold SC (1996) Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Multiple Sclerosis (in press)

    Google Scholar 

  • Wiebe S, Lee DH, Karlik SJ et al. (1992) Serial cranial and spinal cord magnetic resonance imaging in Strategies to Delay the Onset of Clinically Definite Multiple Sclerosis multiple sclerosis. Ann Neurol 32: 643–650

    Article  PubMed  CAS  Google Scholar 

  • Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW (1989) Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 25: 43–49

    Article  PubMed  CAS  Google Scholar 

  • Wucherpfennig KW, Ota K, Endo N et al. (1990) Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science 248: 1016

    Article  PubMed  CAS  Google Scholar 

  • Wucherpfennig KW, Newcombe J, Corner L et al. (1991) Analysis of T-cell receptors in MS plaques. Neurology 41 (Suppl): 380

    Google Scholar 

Download references

Authors
  1. Roy W. Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The UCSF/Mount Zion Multiple Sclerosis Center, University of California at San Francisco, 1600 Divisadero Street, 94115, San Francisco, CA, USA

    Donald E. Goodkin MD

  2. Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, 9500 Euclid Avenue, 44195-5244, Cleveland, OH, USA

    Richard A. Rudick MD

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag London Limited

About this chapter

Cite this chapter

Beck, R.W. (1996). Strategies to Delay the Onset of Clinically Definite Multiple Sclerosis in Patients with Monosymptomatic Presentations of Optic Neuritis, Brainstem Syndromes or Myelopathy. In: Goodkin, D.E., Rudick, R.A. (eds) Multiple Sclerosis. Springer, London. https://doi.org/10.1007/978-1-4471-1271-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1271-6_10

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-033-0

  • Online ISBN: 978-1-4471-1271-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation